RING finger mutations that abolish c-Cbl-directed polyubiquitination and downregulation of the EGF receptor are insufficient for cell transformation

Molecular Cell

Volumn 7, Issue 2, 2001, Pages 355-365

  Thien, Christine B F ^a   Walker, Francesca ^b   Langdon, Wallace Y ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; POLYUBIQUITIN; PROTEIN TYROSINE KINASE; UBIQUITIN CONJUGATING ENZYME;

ALPHA HELIX; ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; ARTICLE; CARCINOGENICITY; CELL TRANSFORMATION; MOUSE; MUTATION; NONHUMAN; PROTEIN DOMAIN; PROTEIN STRUCTURE; PROTO ONCOGENE; RECEPTOR DOWN REGULATION;

ANIMALIA;

EID: 0035106341     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1097-2765(01)00183-6     Document Type: Article

References (44)

1. Tumour induction by activated abl involves tyrosine phosphorylation of the product of the cbl oncogene
2. Leucine zipper-mediated homodimerization of the adaptor protein c-Cbl
3. The sequences of the human and mouse c-cbl proto-oncogenes show v-cbl was generated by a large truncation encompassing a proline-rich domain and a leucine zipper-like motif
4. The truncation that generated the v-cbl oncogene reveals an ability for nuclear transport, DNA binding and acute transformation
5. Phosphotyrosine binding domain-dependent upregulation of the platelet-derived growth factor receptor α signaling cascade by transforming mutants of Cbl: Implications for Cbl's function and oncogenicity
6. The protein product of the c-cbl oncogene rapidly complexes with the EGF receptor and is tyrosine phosphorylated following EGF stimulation
7. Murine epidermal growth factor: Heterogeneity on high resolution ion-exchange
8. Caenorhabditis elegans SOS-1 is necessary for multiple RAS-mediated developmental signals
9. Akt is a direct target of the phosphatidylinositol 3-kinase
10. Fyn, Yes and Syk phosphorylation sites in c-Cbl map to the same tyrosine residues that become phosphorylated in activated T cells
11. Tyrosine phosphorylation of c-Cbl facilitates adhesion and spreading while suppressing anchorage-independent growth of v-Abl-transformed NIH3T3 fibroblasts
12. Protein and cell membrane iodination with a sparingly soluble chloramide, 1,3,4,6-tetrachloro-3a, 6a-diprenylglycoluril
13. Ubiquitination: RING for destruction?
14. Postendocytic trafficking of epidermal growth factor-receptor complexes is mediated through saturable and specific endosomal interactions
15. Site-directed mutagenesis by overlap extension using the polymerase chain reaction
16. The enhanced tumorigenic activity of a mutant epidermal growth factor receptor common in human cancers is mediated by threshold levels of constitutive tyrosine phosphorylation and unattenuated signaling
17. The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase
18. Sli-1, a negative regulator of let-23-mediated signaling in C. elegans
19. The Cbl protooncoprotein stimulates CSF-1 receptor multiubiquitination and endocytosis, and attenuates macrophage proliferation
20. c-Cbl/Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptor
21. Ubiquitin ligase activity and tyrosine phosphorylation underlie suppression of growth factor signaling by c-Cbl/Sli-1
22. The evolutionarily conserved N-terminal region of Cbl is sufficient to enhance down-regulation of the epidermal growth factor receptor
23. Cbl: Complex formation and functional implications
24. Quantitative analysis of the endocytic system involved in hormone-induced receptor internalization
25. A novel PTB domain in the N-terminal transforming region of Cbl interacts directly and selectively wth ZAP-70 in T cells
26. A β1 integrin signaling pathway involving Src-family kinases, Cbl and PI-3 kinase is required for macrophage spreading and migration
27. Structure of the amino-terminal domain of Cbl complexed to its binding site on ZAP-70 kinase
28. The Cbl protooncogene product: From an enigmatic oncogene to center stage of signal transduction
29. Oncogenic forms of Cbl abrogate the anchorage requirement but not the growth factor requirement for proliferation
30. Rapid induction of hemopoietic neoplasms in newborn mice by a raf(mil)/myc recombinant murine retrovirus
31. Src family kinases negatively regulate platelet-derived growth factor α receptor-dependent signaling and disease progression
32. c-Cbl localizes to actin lamellae and regulates lamellipodia formation and cell morphology
33. Transforming ability of MEN2A-RET requires activation of the phosphatidylinositol 3-kinase/AKT signaling pathway
34. Transformation of hematopoietic cells by BCR/ABL requires activation of a PI-3k/Akt-dependent pathway
35. Recognition and specificity in protein tyrosine kinase-mediated signalling
36. EGF receptor binding and transformation by v-cbl is ablated by the introduction of a loss-of-function mutation from the Caenorhabditis elegans sli-1 gene
37. Tyrosine kinase activity of the EGF receptor is enhanced by the expression of oncogenic 70Z-Cbl
38. c-Cbl: A regulator of T cell receptor-mediated signalling
39. The RING finger of c-Cbl mediates desensitization of the epidermal growth factor
40. Ligand-induced transformation by a noninternalizing epidermal growth factor receptor
41. Ligand-induced ubiquitination of the epidermal growth factor receptor involves the interaction of the c-Cbl RING finger and UbcH7
42. Similarity of sli-1, a regulator of vulval development in C. elegans, to the mammalian proto-oncogene c-cbl
43. Requirements of multiple domains of SLI-1, a Caenorhabditis elegans homologue of c-Cbl, and an inhibitory tyrosine in LET-23 in regulating vulval differentiation
44. Structure of a c-Cbl-UbcH7 complex: RING domain function in ubiquitin-protein ligases